New York · 2025 Regular Session · Bill
A 10820: Relates to access to prescription drugs for chronic weight management
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 10820 is a bill introduced in the New York House on April 1, 2026. According to its official title, it concerns: Relates to access to prescription drugs for chronic weight management. Primary sponsor: Jake Blumencranz (Republican/Conservative). Most recent recorded action (April 1, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires managed care providers and the medical assistance program shall cover prescription drugs approved by the federal food and drug administration for chronic weight management in adults with obesity with at least one weight-related condition.
Sponsors
Sponsors by party (alphabetical): Republican/Conservative 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Jake Blumencranz | Primary sponsor | Republican/Conservative | House | 15 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH